Clinical Sequencing
News on sequencing-based testing, NGS gene panels, & diagnostic exomes in genetics, genomics, and molecular diagnostics.
Thermo Fisher Scientific, Pfizer Canada Grant C$300K to Study NGS in Colorectal Cancer Care
The recipients of both grants will study the effects of bringing next-generation sequencing-based testing into a community cancer center.
Quest Diagnostics, Scipher Medicine Collaborate on Rheumatoid Arthritis Test
Quest will provide RNA extraction and sequencing services for Scipher's PrismRA test, a blood-based molecular test for predicting patient response to TNF inhibitors.
GenDx, OSE Immunotherapeutics Ink Deal to Develop NGS CDx for Epitope-Based Cancer Vaccine
Under the deal, GenDx will develop and validate a companion diagnostic test for high-resolution typing of HLA-A*02 based on its IVDR-registered NGS products.
Omixon and GenDx have independently developed nanopore-based HLA typing kits that are currently for research use only but eventually aimed for diagnostic use.
Nanopore Sequencing-Based Method Provides Copy Number Analysis for Brain Tumors in Under Two Hours
Premium
Developed by Dartmouth researchers, the method can be performed in under two hours, offering the potential to classify a tumor in the course of surgery.